tiprankstipranks
Trending News
More News >
Perimeter Medical Imaging AI (TSE:PINK)
:PINK
Canadian Market

Perimeter Medical Imaging AI (PINK) Earnings Dates, Call Summary & Reports

Compare
19 Followers

Earnings Data

Report Date
Sep 02, 2025
TBA Not Confirmed
Period Ending
2025 (Q2)
Consensus EPS Forecast
-0.07
Last Year’s EPS
-0.05
Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings

Earnings Call Summary

Earnings Call Date:May 13, 2025
|
% Change Since: -41.03%
|
Next Earnings Date:Sep 02, 2025
Earnings Call Sentiment|Positive
The earnings call demonstrates strong positive momentum with significant revenue growth, successful trial results, and strategic milestones achieved. Despite an increased net loss and the need for additional capital, the overall sentiment is positive due to the promising progress and future potential of the company's products.
Company Guidance
During the Q1 2025 conference call for Perimeter Medical, the company provided several key financial metrics and strategic updates. The company reported revenue of $550,000 for the quarter ending March 31, 2025, which marked a 460% increase from Q1 2024. Operating expenses remained steady at $4.6 million, while the net loss increased to $4.3 million compared to $2.1 million in the same period in 2024. Cash and cash equivalents stood at approximately $2.4 million, excluding a grant receivable of $931,000. Significant achievements included the first-ever capital unit sale and surpassing $1 million in billings for 2025. The company also expanded into three new states: New Mexico, Tennessee, and Arizona. Strategically, Perimeter is focusing on the commercialization of its FDA-cleared S-Series OCT system and pursuing FDA approval for its B-Series OCT system with ImgAssist AI 2.0, which recently showed promising results in a pivotal clinical trial. The company is also working on broadening its user base and preparing for a potential full commercial launch contingent upon FDA approval of the B-Series.
Significant Revenue Increase
The company recorded a revenue of $550,000 for the first quarter of 2025, marking a 460% increase over Q1 2024.
Commercial Milestones Achieved
Perimeter achieved multiple commercial milestones including the first capital unit sale, record patient cases, and the highest number of consumables shipped.
Successful Pivotal Trial for B-Series
The pivotal trial for the B-Series OCT system met its primary endpoint with a statistically significant reduction in patients with residual cancer, achieving a margin accuracy of 88.1%.
FDA Pre-Market Approval Application
The company filed a pre-market approval application for the B-Series OCT with the FDA in March 2025 and engaged in positive dialogue with the agency.
Presentation at ASBrS Conference
Dr. Alastair Thompson presented detailed study results of the B-Series pivotal trial at the ASBrS conference, drawing significant attention from researchers and clinicians.

Perimeter Medical Imaging AI (TSE:PINK) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

TSE:PINK Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Sep 02, 2025
2025 (Q2)
-0.07 / -
-0.05
May 13, 2025
2025 (Q1)
- / -0.07
-0.041-66.67% (-0.03)
Mar 26, 2025
2024 (Q4)
-0.07 / -0.05
-0.1150.00% (+0.05)
Nov 14, 2024
2024 (Q3)
- / -0.10
-0.014-600.00% (-0.08)
Aug 14, 2024
2024 (Q2)
-0.08 / -0.07
-0.1137.50% (+0.04)
May 14, 2024
2024 (Q1)
-0.08 / -0.04
-0.06940.00% (+0.03)
Mar 28, 2024
2023 (Q4)
-0.06 / -0.11
-0.062-77.78% (-0.05)
Nov 14, 2023
2023 (Q3)
-0.07 / -0.01
-0.011-25.00% (>-0.01)
Aug 29, 2023
2023 (Q2)
-0.10 / -0.11
-0.011-900.00% (-0.10)
May 25, 2023
2023 (Q1)
- / -
-0.085
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

TSE:PINK Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 13, 2025
C$0.39C$0.46+17.95%
Mar 26, 2025
C$0.58C$0.57-1.72%
Nov 14, 2024
C$0.46C$0.50+8.70%
Aug 14, 2024
C$0.36C$0.360.00%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Perimeter Medical Imaging AI (TSE:PINK) report earnings?
Perimeter Medical Imaging AI (TSE:PINK) is schdueled to report earning on Sep 02, 2025, TBA Not Confirmed.
    What is Perimeter Medical Imaging AI (TSE:PINK) earnings time?
    Perimeter Medical Imaging AI (TSE:PINK) earnings time is at Sep 02, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is TSE:PINK EPS forecast?
          TSE:PINK EPS forecast for the fiscal quarter 2025 (Q2) is -0.07.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis